Remove practice-areas psychedelics
article thumbnail

From MMJ to Special K

Project CBD

“Special K” acquired a reputation as a party drug in the 1970s due to its psychedelic and mood-altering effects. But there’s no natural correlate for synthetic ketamine, which works through different molecular pathways than the classic, naturally sourced psychedelics.

article thumbnail

Best Lawyers® Recognizes Seven Attorneys From National Cannabis Law Firm Vicente Sederberg LLP

Cannabis Law Report

Four additional VS attorneys were included in Best Lawyers: Ones to Watch , which recognizes associates and other lawyers who are earlier in their careers for their outstanding professional excellence in private practice. New York-based counsel Shane Pennington was recognized for his Appellate Practice.

Law 116
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

MAPS Is Pushing For FDA Approval Of MDMA-Assisted Therapy

Veriheal

MAPS Public Benefit Corporation (PBC), an arm of the Multidisciplinary Association for Psychedelic Studies , has made big strides recently encouraging the Food and Drug Administration (FDA) to consider approving MDMA, also known as molly or ecstasy, for MDMA-assisted therapy.

Therapy 109
article thumbnail

Is There Any Difference Between THC and THC-O?

Cannabis Law Report

The high that THC-O-Acetate delivers is much more psychedelic in nature. Even a low dose of THC-O-Acetate is enough to stimulate some psychedelic effects in the body. When moderate amounts of THC-O-Acetate are in the picture, the experiences are almost identical to traditional psychedelics.

THC 122
article thumbnail

Three New Studies on Cannabis and PTSD

Project CBD

In fact, according to a few quick searches of PubMed, cannabis has a longer and richer association with PTSD in the scientific literature than any psychedelic. An independent science journalist based in the San Francisco Bay Area, he covers a wide range of subjects, including environmental health, neuroscience, and pharmacology.

Sleep 130
article thumbnail

Ehave, Inc. ramps up to begin clinical trials by adding esteemed medical professional to its medical advisory board.

Cannabis Law Report

OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today Dr. Nitin Desai consented to join the Company’s Medical Advisory Board. Research in the area of mental health has been Dr. Nitin Desai’s passion. Ben Kaplan, CEO of Ehave, Inc. Ehave, Inc.

article thumbnail

Knowde Group Inc.™ Enters Into a Strategic Partnership with LMC Manna Research to Drive Quality and Collaboration in the Conduct of Cannabis and Psychedelic Clinical Trials.

Cannabis Law Report

There is an urgent need for objective, scientifically sound and robust clinical trials to support medicinal cannabis and psychedelics (psilocybin, MDMA, LSD, Ketamine). Therapeutic areas include psychiatry, pain management, neurology, dermatology, smoking cessation and community-based oncology research.